Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

1Y2F

Crystal Structure of ZipA with an inhibitor

Summary for 1Y2F
Entry DOI10.2210/pdb1y2f/pdb
Related1Y2G
DescriptorCell division protein zipA, 4-{2-[4-(2-AMINOETHYL)PIPERAZIN-1-YL]PYRIDIN-4-YL}-N-(3-CHLORO-4-METHYLPHENYL)PYRIMIDIN-2-AMINE (3 entities in total)
Functional Keywordscell cycle
Biological sourceEscherichia coli
Cellular locationCell inner membrane; Single-pass type I membrane protein: P77173
Total number of polymer chains1
Total formula weight15957.61
Authors
Mosyak, L.,Rush, T.S. (deposition date: 2004-11-22, release date: 2005-03-01, Last modification date: 2023-08-23)
Primary citationRush, T.S.,Grant, J.A.,Mosyak, L.,Nicholls, A.
A shape-based 3-D scaffold hopping method and its application to a bacterial protein-protein interaction
J.Med.Chem., 48:1489-1495, 2005
Cited by
PubMed Abstract: In this paper, we describe the first prospective application of the shape-comparison program ROCS (Rapid Overlay of Chemical Structures) to find new scaffolds for small molecule inhibitors of the ZipA-FtsZ protein-protein interaction, a proposed antibacterial target. The shape comparisons are made relative to the crystallographically determined, bioactive conformation of a high-throughput screening (HTS) hit. The use of ROCS led to the identification of a set of novel, weakly binding inhibitors with scaffolds presenting synthetic opportunities to further optimize biological affinity and lacking development issues associated with the HTS lead. These ROCS-identified scaffolds would have been missed using other structural similarity approaches such as ISIS 2D fingerprints. X-ray crystallographic analysis of one of the new inhibitors bound to ZipA reveals that the shape comparison approach very accurately predicted the binding mode. These experimental results validate this use of ROCS for chemotype switching or "lead hopping" and suggest that it is of general interest for lead identification in drug discovery endeavors.
PubMed: 15743191
DOI: 10.1021/jm040163o
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2 Å)
Structure validation

236371

PDB entries from 2025-05-21

PDB statisticsPDBj update infoContact PDBjnumon